Education
About Us
Working with TipRanks
Follow Us
Epsilon Healthcare Limited (HDRPF)
OTHER OTC:HDRPF
HDRPF Stock Chart & Stats
$0.01
>-$0.01(0.00%)
At close: 4:00 PM EST
$0.01
>-$0.01(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume8.00K
Average Volume (3M)N/A
Market Cap
$7.05M
Enterprise Value$24.03M
Total Cash (Recent Filing)$242.86K
Total Debt (Recent Filing)$14.16M
Price to Earnings (P/E)―
Beta0.06
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding389,104,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)4.19
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market Cap3.41
Enterprise Value/Revenue2.56
Enterprise Value/Gross Profit224.09
Enterprise Value/Ebitda12.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross Profit MarginA gross profit margin of 74.52% indicates the company’s products or inputs have strong unit economics and pricing power. Over the medium term this margin provides a durable buffer to absorb SG&A and R&D spend, enabling path to operating leverage if revenue stabilizes or cost structure is improved.
Manageable Leverage On Balance SheetA debt-to-equity ratio around 0.74 suggests leverage is moderate and not excessive for a development-stage healthcare company. This structural position preserves borrowing capacity and reduces near-term solvency risk, giving management flexibility to fund trials, partnerships, or commercialization without immediate distress.
Diversified Revenue Streams And PartnershipsMultiple revenue sources — product sales, licensing, partnerships and government grants — reduce single-channel dependence and support longer-term resilience. Strategic partnerships and licensing can accelerate commercialization, share development risk, and expand market access, structurally improving the business model's scalability.
Bears Say
Persistent Revenue DeclineA 26.08% recent revenue decline and negative revenue growth trend weaken scale economics and make fixed costs harder to cover. Over several months this erodes the company’s ability to invest in R&D, commercial expansion and regulatory support, hindering realization of gross margin advantages and long-term growth plans.
Large Operating Losses And Negative MarginsDeep operating losses and very negative EBIT and net margins indicate structural inefficiencies or high fixed costs relative to revenue. Persisting at this scale will consume equity and require repeated financing, reducing flexibility and increasing execution risk for long-term development and commercialization initiatives.
Negative Operating Cash Flow Despite FCF GrowthNegative operating cash flow signals core operations do not generate sustainable cash, forcing reliance on external funding or one-off items. Although free cash flow grew, that may reflect timing or non-recurring items; structurally weak operating cash conversion raises liquidity and financing risk over the coming months.
Epsilon Healthcare Limited News
HDRPF FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is $7.05M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Epsilon Healthcare Limited’s earnings last quarter?
Currently, no data Available
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in HDRPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-74.34%
Trailing 12-Months
Asset Growth
84.04%
Trailing 12-Months
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.